We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India, China to Top API Supply Heap Despite Rising Costs, Analysts Say
India, China to Top API Supply Heap Despite Rising Costs, Analysts Say
December 6, 2011
Despite increasing costs and a shaky quality record, India and China will continue for now to supply active pharmaceutical ingredients (API) at a steady clip, outpacing other foreign suppliers, industry analysts predict.